Pheon Therapeutics in a $120m Series B led by TCGX, joined by BVF Partners, Lightspeed, Perceptive Advisors, Atlas Venture, Brandon Capital, Forbion

Biotech Health services Pharma

United Kingdom

Australia

Netherlands

United States

Investments

14 May 2024

Share:

Pheon Therapeutics (company)

United Kingdom

Biotech Health services Pharma

Total investments received (USD): 188m

Round value (USD): 120m

Round investors: Brandon Capital Partners Forbion Capital Partners Lightspeed Venture Partners Research Corporation Technologies Atlas Venture Perceptive Advisors TCGX BVF Partners

Company: Pheon Therapeutics

Industry: Biotech Health services Pharma

Related deals

Purespring Therapeutics raised £80M series B led by Sofinnova Partners, joined by British Patient Capital, Syncona, Gilde Healthcare and Forbion.

Biotech Health services

United Kingdom

Netherlands

France

Investments 02 October 2024

Vicebio raised $100M with TCG Crossover, venBio Partners, UniQuest, Medicxi, Goldman Sachs Alternatives and Avoro Ventures

Biotech Health services

United Kingdom

United States

South Korea

Investments 17 September 2024

F2G raised a $100m round co-led AMR Action Fund and ICG, joined by Novo, Advent Life, Sofinnova, Forbion, Blue Owl, Morningside, and Merifin Capital.

Biotech Health services Pharma

United Kingdom

United States

Netherlands

Denmark

France

Belgium

Investments 01 September 2024

Exscientia to merge operations with Recursion from the US in a $668m deal

Biotech Health services Pharma Software Services

United Kingdom

MA 02 August 2024

Myricx Bio raised $114m in Series A funding co-led by Abingworth and Novo Holdings, joined by insiders Brandon Capital and Sofinnova Partners.

Health services Pharma

United Kingdom

Australia

Denmark

France

Investments 01 July 2024